DexCom (DXCM) Revenue — Quarter Ended Mar 31, 2026
Revenue for the period decreased from the prior period but increased compared to the same period one year earlier. The trailing twelve-month revenue remained relatively stable.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue for the period decreased from the prior period but increased compared to the same period one year earlier. The trailing twelve-month revenue remained relatively stable.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
-5.4%
Change from the immediately preceding quarter.
Year-over-year
+15.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $1.2B | +15.2% |
| Sep 30, 2025 | $1.2B | +21.6% |
| Dec 31, 2025 | $1.3B | +13.1% |
| Mar 31, 2026 | $1.2B | +15.0% |
Revenue performance
The reported revenue moved lower sequentially, reflecting a decline from the prior period's level.
Quarterly comparison
Compared to the immediately preceding period, revenue was lower. However, when measured against the same period one year earlier, revenue showed an increase.
What to watch
The sequential decline in revenue is a factor to monitor in upcoming periods.